Loan, 22, suffered a hemorrhagic stroke caused by a cerebral arteriovenous malformation and was saved by timely emergency intervention by doctors.

A patient died after receiving Pfizer Inc.’s drug for hemophilia, marking another setback for the company in the treatment of ...

A patient who was being treated with Pfizer's hemophilia drug, Hympavzi, as part of a long-term study died after experiencing ...

Science Signaling retracted a 2017 paper that linked a specific amyloid form (amyloid-beta 56) to tau pathology after an ...

New cardiovascular research shows untreated gum disease may independently worsen artery health and increase long term risks of heart disease and stroke.

A patient in an open label extension study of Pfizer’s hemophilia treatment Hympavzi has died, the company and several ...

THE HSE have issued an urgent Christmas alert over a “life-threatening condition” that impacts 1 in 4 – here’s the warning ...

Investing.com -- A patient died after receiving Pfizer Inc.’s (NYSE:PFE) hemophilia drug Hympavzi, adding to challenges for the company in blood disorder treatments.

The patient, who died on December 14, was originally enrolled in a Phase III study in 2022 and transitioned into an extension phase in 2023.

Chronic sleep deprivation acts as a systemic stressor, elevating risks for cardiovascular disease and metabolic dysregulation while impairing cognitive function.

Operations face being cancelled if the first ever resident doctors strike in Scotland, planned for the second week of January ...

From treating injuries to handling altitude sickness and emergencies, here’s a doctor-approved first-aid guide every trekker, camper, and pilgrim should know.